Doctor's Notes - IMAC Blog

IMAC Holdings Receives FDA Authorization to Initiate Clinical Study of Its Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease

BRENTWOOD, Tenn., August 5, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or...

IMAC Regeneration: Top Doctors for DOL and Federal Employees Injured at Work

IMAC is now accepting Federal Employees Injured at Work IMAC Regeneration Centers is proud to be a provider in network with the Department of Labor Office of Workers Compensation Programs. If you or someone you love has covered benefits with the Federal Employees...
IMAC PRP for Neuropathy

PRP for Neuropathy & Why Medications Aren’t the Solution

Treating Neuropathy: Why Medications Aren’t The Solution Did you miss our first post in this blog series about neuropathy? If so, read it here. Today, we'll review two types of drugs that are commonly used to treat neuropathy, and IMAC solution for neuropathy that...
7 Ways to Increase Your Activity

7 Ways to Increase Your Activity

Have you become less active in recent years? It’s important to remain physically active in order to stay as healthy as possible. It isn’t always easy to stay active, especially if you’re already struggling with limited mobility. There are several easy ways to increase...

read more

Committed to Success without surgery.